7Baggers
Quarterly
Annual
    Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-06-30 2022-03-31 2021-09-30 
      
    		           
      cash flows from operating activities:
    		           
      net income
    		-77,112,000 15,981,000 -120,656,000 4,596,000 15,096,000 18,777,000 -23,447,000 759,615 -429,135 -320,455  
      adjustments to reconcile net income to net cash from operating activities:
    		           
      depreciation
    		482,000 423,000 414,000 432,000 329,000 319,000 296,000     
      bad debt expense
    		0 -1,220,000 1,660,000         
      impairment of property and equipment
    		           
      share-based compensation expense
    		1,285,000 1,969,000 3,926,000 1,525,000 1,556,000 985,000 207,000     
      change in fair value of safe agreements
    		   0 0 0 2,353,000     
      change in fair value of earn-out liabilities
    		33,328,000 -22,109,000 22,597,000 -5,186,000 -36,036,000 -28,756,000 3,726,000     
      change in fair value of warrant liabilities
    		33,686,000 -21,009,000 23,964,000 -5,176,000        
      loss on issuance of securities
    		0 -596,000 68,676,000 0        
      other
    		-46,000   18,000 7,000 -564,000 582,000     
      changes in operating assets and liabilities:
    		           
      trade accounts receivable
    		-13,050,000 -1,819,000 -20,002,000 -14,429,000 777,000 -85,000 -1,006,000     
      contract assets
    		-14,249,000 12,523,000 -13,357,000 -4,484,000 2,702,000 6,999,000 -4,727,000     
      prepaid expenses
    		117,000 -477,000 305,000 36,000 683,000 631,000 -2,785,000     
      other assets
    		608,000 -185,000 429,000 626,000 181,000 180,000 178,000   110,728  
      accounts payable and accrued expenses
    		-4,951,000 -23,513,000 30,658,000         
      accounts payable – affiliated companies
    		-2,019,000 -2,154,000 4,411,000 2,432,000 59,000 389,000 170,000     
      contract liabilities – current and long-term
    		15,958,000 11,528,000 -13,172,000 -4,735,000 9,592,000 -10,050,000 -8,140,000     
      other liabilities
    		2,999,000 -756,000 3,705,000 -6,068,000 8,763,000 7,564,000 6,933,000     
      net cash from operating activities
    		-17,920,000 -31,260,000 -6,442,000 -22,346,000 -7,159,000 2,892,000 -18,666,000 -504,510 -356,978 -195,827  
      capex
    		-1,392,000 -2,205,000 -1,588,000 -2,243,000 -7,468,000 -11,635,000 -8,565,000 0 0 0  
      free cash flows
    		-19,312,000 -33,465,000 -8,030,000 -24,589,000 -14,627,000 -8,743,000 -27,231,000 -504,510 -356,978 -195,827  
      cash flows from investing activities:
    		           
      purchase of property and equipment
    		-1,392,000 -2,205,000 -1,588,000 -2,243,000 -7,468,000 -11,635,000 -8,565,000     
      net cash from investing activities
    		-1,392,000 -2,205,000 -1,588,000 -2,243,000 -7,468,000 -11,635,000 -8,565,000     
      cash flows from financing activities:
    		           
      proceeds from business combination
    		   0 0 0 8,055,000     
      proceeds from issuance of series a preferred stock
    		   0        
      transaction costs
    		0   0 0 -8,589,000 -782,000     
      proceeds from borrowings
    		0 0 10,000,000         
      repayment of loans
    		-3,000,000 -5,000,000 -10,000,000         
      proceeds from issuance of securities
    		80,454,000 17,481,000 10,000,000 0        
      member distributions
    		   0 -3,689,000       
      stock option exercises
    		0 135,000 165,000         
      payment of withholding taxes from share-based awards
    		-168,000           
      forward purchase agreement termination
    		   0 0 0 12,730,000     
      warrants exercised
    		0 771,000 50,589,000 0 0 13,881,000 2,243,000     
      contributions from (distributions to) noncontrolling interests
    		           
      net cash from financing activities
    		77,286,000 9,854,000 60,754,000 -11,565,000 16,192,000 1,029,000 48,268,000 500,000    
      net increase in cash, cash equivalents and restricted cash
    		57,974,000 -23,611,000 52,724,000  1,565,000 -7,714,000 21,037,000     
      cash, cash equivalents and restricted cash at beginning of the period
    		0 0 4,560,000 0 0 0 25,826,000     
      cash, cash equivalents and restricted cash at end of the period
    		57,974,000 -23,611,000 57,284,000 -36,154,000 1,565,000 -7,714,000 46,863,000     
      less: restricted cash
    		0 0 2,042,000 0 0 0 62,000     
      cash and cash equivalents at end of the period
    		57,974,000 -23,611,000 55,242,000 -36,154,000 1,565,000 -7,714,000 46,801,000     
      supplemental disclosure of cash flow information
    		           
      cash paid for interest
    		37,000 159,000 212,000   508,000 464,000     
      cash paid for taxes
    		3,000     25,000 9,000     
      accrued capital expenditures
    		           
      noncash operating activities:
    		           
      right-of-use assets obtained in exchange for new operating liabilities
    		           
      noncash financing activities:
    		           
      safe agreements
    		           
      class a common stock related to equity facility
    		           
      conversion of series a preferred stock
    		0 0 23,120,000         
      preferred dividends
    		-143,000 -137,000 -471,000   -655,000 -328,000     
      distribution to noncontrolling interests
    		           
      bad debt (recoveries) expense
    		           
      loss on disposal of property and equipment
    		           
      deferred income taxes
    		           
      net costs of stock option exercises
    		   -55,000        
      investment from non-controlling interests
    		   490,000        
      net decrease in cash, cash equivalents and restricted cash
    		           
      recoveries of bad debt expense
    		           
      accounts payable
    		    -6,378,000 6,379,000 6,994,000     
      proceeds from series a preferred stock
    		     0 26,000,000     
      proceeds from stock option exercises
    		           
      class a common stock related to cef
    		           
      proceeds from issuance of units
    		      22,000     
      formation cost paid by sponsor in exchange of issuance of class b ordinary shares
    		           
      operating expense paid by promissory note - related party
    		           
      change in fair value of over-allotment
    		           
      issuance cost of over-allotment
    		           
      interest earned on marketable securities held in trust account
    		       -2,846,977 -495,758 -27,414  
      prepaid assets
    		       121,959 211,807 -35,852  
      due to related party
    		       2,448 26,468 -1,032  
      accrued offering costs and expenses
    		       1,458,445 329,640 78,198  
      investment of cash in trust account
    		           
      proceeds from issuance of private placement warrants
    		           
      proceeds from sale of units, net of underwriting discount
    		           
      payment of promissory note – related party
    		           
      proceeds from working capital loan
    		       500,000    
      payment of offering costs
    		           
      net change in cash and cash equivalents
    		           
      cash and cash equivalents – beginning
    		           
      cash and cash equivalents– ending
    		           
      non-cash investing and financing activities:
    		           
      offering costs paid by sponsor in exchange for issuance of class b ordinary shares
    		           
      offering costs paid by promissory note - related party
    		           
      capital contribution for excess fair value of class b shares sold by the sponsor to anchor investors determined to be offering cost
    		           
      deferred underwriting commissions payable charged to additional paid in capital
    		           
      remeasurement of class a ordinary shares subject to possible redemption
    		           
      reduction of deferred underwriting fee
    		           
      accrued offering costs
    		           
      operating costs paid by related party
    		           
      changes in current assets and liabilities:
    		           
      net change in cash
    		        -356,978 -195,827  
      cash, beginning of the period
    		        359,610 359,610  
      cash, end of the period
    		        2,632 163,783  
      supplemental disclosure of non-cash financing activities:
    		           
      re-measurement of class a ordinary shares subject to possible redemption
    		        501,556   
      ●
    		           
      basic and diluted net income per share:
    		           
      numerator:
    		           
      allocation of net income
    		        -86,944 -256,364  
      denominator:
    		           
      basic and diluted weighted-average shares outstanding
    		        32,975,000 32,975,000  
      basic and diluted net income per share
    		        0 -0.01  
      weighted-average shares outstanding
    		          22,826,097,500,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.